Vital Farms (NASDAQ:VITL) Reaches New 52-Week High After Analyst Upgrade

Vital Farms, Inc. (NASDAQ:VITLGet Free Report) hit a new 52-week high on Monday after Stifel Nicolaus raised their price target on the stock from $22.00 to $30.00. Stifel Nicolaus currently has a buy rating on the stock. Vital Farms traded as high as $27.41 and last traded at $27.21, with a volume of 36901 shares trading hands. The stock had previously closed at $27.00.

Other analysts have also recently issued research reports about the stock. William Blair started coverage on shares of Vital Farms in a research note on Wednesday, April 10th. They set an “outperform” rating for the company. TheStreet upgraded shares of Vital Farms from a “c” rating to a “b-” rating in a research note on Monday, March 18th. Finally, Lake Street Capital raised their price target on Vital Farms from $26.00 to $32.00 and gave the stock a “buy” rating in a report on Wednesday, April 24th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $23.00.

Check Out Our Latest Research Report on Vital Farms

Insider Buying and Selling

In related news, CEO Russell Diez-Canseco sold 27,528 shares of the business’s stock in a transaction dated Monday, February 12th. The shares were sold at an average price of $15.49, for a total value of $426,408.72. Following the sale, the chief executive officer now directly owns 223,568 shares in the company, valued at approximately $3,463,068.32. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. In other Vital Farms news, CEO Russell Diez-Canseco sold 27,528 shares of the stock in a transaction on Monday, February 12th. The stock was sold at an average price of $15.49, for a total transaction of $426,408.72. Following the sale, the chief executive officer now owns 223,568 shares in the company, valued at approximately $3,463,068.32. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, COO Jason Dale sold 14,006 shares of the business’s stock in a transaction dated Tuesday, February 20th. The shares were sold at an average price of $16.03, for a total transaction of $224,516.18. Following the completion of the transaction, the chief operating officer now directly owns 48,455 shares of the company’s stock, valued at approximately $776,733.65. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 260,125 shares of company stock valued at $5,580,996. 30.20% of the stock is owned by insiders.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in Vital Farms by 52.8% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,196 shares of the company’s stock worth $95,000 after buying an additional 2,833 shares during the period. Tower Research Capital LLC TRC lifted its holdings in shares of Vital Farms by 211.4% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,175 shares of the company’s stock worth $97,000 after acquiring an additional 4,192 shares during the period. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Vital Farms in the third quarter worth approximately $119,000. DekaBank Deutsche Girozentrale acquired a new position in shares of Vital Farms in the 4th quarter valued at $127,000. Finally, New York State Common Retirement Fund increased its holdings in shares of Vital Farms by 49.0% during the 4th quarter. New York State Common Retirement Fund now owns 10,169 shares of the company’s stock worth $160,000 after buying an additional 3,346 shares during the last quarter. 98.59% of the stock is currently owned by institutional investors and hedge funds.

Vital Farms Stock Down 0.6 %

The firm has a market capitalization of $1.12 billion, a PE ratio of 46.28 and a beta of 0.88. The company has a current ratio of 3.00, a quick ratio of 2.49 and a debt-to-equity ratio of 0.05. The firm has a 50-day moving average of $22.41 and a two-hundred day moving average of $16.83.

Vital Farms (NASDAQ:VITLGet Free Report) last released its quarterly earnings data on Thursday, March 7th. The company reported $0.17 earnings per share for the quarter, beating the consensus estimate of $0.14 by $0.03. Vital Farms had a return on equity of 14.22% and a net margin of 5.42%. The business had revenue of $135.81 million for the quarter, compared to analyst estimates of $131.10 million. During the same period in the previous year, the company posted $0.04 EPS. On average, equities research analysts forecast that Vital Farms, Inc. will post 0.77 EPS for the current year.

Vital Farms Company Profile

(Get Free Report)

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.

Read More

Receive News & Ratings for Vital Farms Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vital Farms and related companies with MarketBeat.com's FREE daily email newsletter.